J&J and other drugmakers go on trial over US opioid crisis
6 years ago(FILES) In this file photo the Johnson & Johnson logo is seen above an entrance to a building at their campus in Irvine, California on August 28, 2019. The US government on August 5, 2020 announced a new $1 billion investment in a COVID-19 vaccine being developed by Johnson & Johnson, guaranteeing 100 million doses. J&J, via its subsidiary Janssen, had already received $456 million in March. The new money will allow the company to ramp up production so that doses are ready for shipping if and when the drug receives regulatory approval. Mark RALSTON / AFP
Drugmakers including Johnson & Johnson on Tuesday denied claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed addiction risks, as the trial in a lawsuit filed by several municipalities got underway.